Results 91 to 100 of about 36,088 (121)
Cell cycle proteins: Linking the cell cycle to tumors. [PDF]
Zhong J +11 more
europepmc +1 more source
Genome-wide screen reveals dependence of break induced replication on several distinct checkpoints. [PDF]
Liu L +8 more
europepmc +1 more source
YK-4-279 Induces Osteosarcoma Cell Cycle Arrest, DNA Damage Response, and Apoptosis by Regulating the MAPK Cascade. [PDF]
Wang W, Zhang Y, Jia X, Han L, Xin M.
europepmc +1 more source
IFN It Isn't Broke, It May Still Be Driving Disease: IFNs as Mediators of Senescence in Chronic Obstructive Pulmonary Disease. [PDF]
Nguyen JP, Sauler M.
europepmc +1 more source
Claspin and Cancer: Where Are We Now? [PDF]
Azenha D, Martins TC.
europepmc +1 more source
KRAS-induced STN1 (OBFC1) promotes proper CTC1-STN1-TEN1 complex-independent DNA double-strand break repair and cell cycle checkpoint maintenance in pancreatic cancer. [PDF]
Shen C +15 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Molecular Carcinogenesis, 2006
AbstractIn this study, we first demonstrated that loratadine (LOR), a promising world widely used oral anti‐histamine, effectively inhibits growth of tumors derived from human colon cancer cells (COLO 205) in an in vivo setting. In vitro study demonstrated that the anti‐tumor effects of LOR in COLO 205 cells were mediated by causing G2/M phase cell ...
Jinn-Shiun, Chen +7 more
openaire +2 more sources
AbstractIn this study, we first demonstrated that loratadine (LOR), a promising world widely used oral anti‐histamine, effectively inhibits growth of tumors derived from human colon cancer cells (COLO 205) in an in vivo setting. In vitro study demonstrated that the anti‐tumor effects of LOR in COLO 205 cells were mediated by causing G2/M phase cell ...
Jinn-Shiun, Chen +7 more
openaire +2 more sources
Journal of experimental therapeutics & oncology, 2011
Triazoloacridone C-1305, a new topoisomerase II inhibitor, exhibits potent cytostatic activity toward various tumours under in vitro and in vivo conditions. Interestingly, mouse cells lacking poly(ADP-ribose) polymerase-1 are much more sensitive to C-1305 than their normal counterparts.
Margarita, Maurer +3 more
openaire +1 more source
Triazoloacridone C-1305, a new topoisomerase II inhibitor, exhibits potent cytostatic activity toward various tumours under in vitro and in vivo conditions. Interestingly, mouse cells lacking poly(ADP-ribose) polymerase-1 are much more sensitive to C-1305 than their normal counterparts.
Margarita, Maurer +3 more
openaire +1 more source

